Related Experiment Video
Updated: Apr 4, 2026

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
Published on: September 13, 2022
Medical expulsive treatment in pediatric urolithiasis
1Department of Urology, Karabük University Faculty of Medicine, Karabük, Turkey.
Insights
Pediatric stone disease, affecting 0.1-5% of children, necessitates effective treatments. Medical expulsive therapy offers a less invasive, cost-effective alternative to surgery for childhood urolithiasis.
Area of Science:
- Pediatric Urology
- Nephrology
- Pharmacology
Background:
- Childhood stone disease (urolithiasis) prevalence ranges from 0.1% to 5%, influenced by environmental, metabolic, anatomical, infectious, and nutritional factors.
- Established treatments like percutaneous nephrolithotomy, ureterorenoscopy, and extracorporeal shock wave lithotripsy carry risks and costs.
- Medical expulsive treatment (MET) has emerged as a viable, less invasive alternative for select pediatric urolithiasis cases.
Purpose of the Study:
- To review the necessity and application of medical expulsive treatment for pediatric stone disease.
- To guide the selection of appropriate drugs based on stone characteristics and patient factors.
- To discuss the optimal duration for medical expulsive therapy in childhood urolithiasis.
Main Methods:
- Review of existing literature on medical expulsive treatments for pediatric urolithiasis.
- Analysis of various drug classes used in MET, including NSAIDs, antimuscarinics, PDE5 inhibitors, steroids, calcium channel blockers, and alpha blockers.
- Consideration of factors influencing drug choice: stone location, size, composition, technology, cost, and clinician/parent preferences.
Main Results:
- Medical expulsive therapy presents a cost-effective and less invasive option compared to surgical interventions for pediatric urolithiasis.
- Drug selection for MET is multifactorial, requiring careful consideration of stone parameters and patient-specific variables.
- Evidence supports the efficacy of various pharmacological agents in facilitating stone expulsion in children.
Conclusions:
- Medical expulsive treatment is a valuable component in the management of childhood urolithiasis, offering an alternative to invasive procedures.
- Personalized drug selection and treatment duration are crucial for optimizing outcomes in pediatric patients undergoing MET.
- Further research may refine guidelines for MET in pediatric urolithiasis, enhancing its role in clinical practice.
Abstract:
The frequency of stone disease in childhood ranges between 0.1-5 percent. Stone disease occurs as a result of enviromental, metabolic, anatomical, infectious and nutritional factors. Percutaneous nephrolitotomy, uretherorenoscopy, laparoscopic surgery, open surgery and extracorporeal shock wave lithothripsy are treatment alternatives for stone disease during childhood. However, these methods are not completely innocent. Some complications may occur after these procedures. These procedures are generally not cost- effective. Even invasive procedures have high success rates, so medical expulsive treatment modalities have become an alternative for a group of patients. Nonsteroidal anti- inflammatory drugs, antimuscarinic drugs, phospodiesterase type 5 inhibitors, steroids, calcium channel blockers and alpha blockers are treatment alterneatives used for this modality in the literature. The drug is chosen according to the location, size, and composition of the stone, recent technology, cost, surgeon's experience and surgeon's and the parents' preferences. In this review article the following topics will be discussed such as "Why medical expulsive treatment is needed during childhood? Which drug should be chosen for which stone type? How long should a treatment of urolithiasis last?
Related Concept Videos
Urinary Tract Calculi VI: Surgical Management
Urinary Tract Calculi III: Medical Management
Urologic Endoscopic Procedure: Cystoscopic Examination
Urinary Tract Calculi V: Nursing Management
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Pharmacokinetics in Pediatric Patients: Drug Excretion
